Clorox (NYSE:CLX – Get Free Report) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Monday, Zacks reports.
A number of other brokerages have also recently issued reports on CLX. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. Evercore set a $99.00 price target on shares of Clorox in a research report on Tuesday, August 4th. Wells Fargo & Company reduced their price objective on shares of Clorox from $102.00 to $90.00 and set an “equal weight” rating for the company in a research note on Friday, September 11th. Deutsche Bank Aktiengesellschaft set a $98.00 target price on shares of Clorox in a research note on Tuesday, August 4th. Finally, Citigroup dropped their target price on shares of Clorox from $100.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, September 11th. Thirteen research analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $101.40.
Get Our Latest Analysis on CLX
Clorox Price Performance
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same quarter in the prior year, the firm posted $2.87 EPS. The firm’s revenue for the quarter was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, equities research analysts predict that Clorox will post 5.8 EPS for the current fiscal year.
Hedge Funds Weigh In On Clorox
A number of institutional investors and hedge funds have recently bought and sold shares of CLX. Anchor Investment Management LLC boosted its position in shares of Clorox by 13.0% in the second quarter. Anchor Investment Management LLC now owns 14,719 shares of the company’s stock worth $1,405,000 after purchasing an additional 1,699 shares during the period. Miramontes Capital LLC bought a new stake in shares of Clorox during the 2nd quarter valued at $319,000. Tidal Investments LLC raised its position in shares of Clorox by 26.4% during the 2nd quarter. Tidal Investments LLC now owns 38,464 shares of the company’s stock valued at $3,671,000 after purchasing an additional 8,031 shares during the period. National Pension Service lifted its stake in shares of Clorox by 29.7% during the 2nd quarter. National Pension Service now owns 31,827 shares of the company’s stock valued at $3,038,000 after buying an additional 7,291 shares in the last quarter. Finally, RFG Advisory LLC lifted its stake in shares of Clorox by 7.3% during the 2nd quarter. RFG Advisory LLC now owns 3,418 shares of the company’s stock valued at $326,000 after buying an additional 232 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.
About Clorox
The Clorox Company (NYSE: CLX) is a consumer products company that develops, manufactures and markets household, health and wellness, and lifestyle products. Its portfolio includes cleaning and disinfecting products, laundry and home-care items, food products, personal-care products, water-filtration systems, charcoal, and cat litter.
Clorox’s brands include Clorox bleach and disinfecting products, Pine-Sol, Fresh Step and Scoop Away, Kingsford, Brita, Burt’s Bees, Hidden Valley, and products marketed under the Glad name.
See Also
- Five stocks we like better than Clorox
- Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
